NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Andira Pharmaceuticals

Andira Pharmaceuticals

Private
VancouverHealthcare & Life Scienceshttps://andira.ca/

Last Round

Seed Round

Mar 12, 2026

Total Funding Raised

$140,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Andira Pharmaceuticals is a biotechnology company that develops cannabinoid-based therapeutics and medical devices for infection control, post-surgical recovery, and breast cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cannabinoid therapeuticsantimicrobial technologybiopharmaceuticalmedical devicesantimicrobial resistanceAMRwound caredrug delivery platformpost-surgical recoveryinfection controlcannabis biotechpain managementclinical trialsdrug discoverymedical cannabis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Andira Pharmaceuticals Comparables

Compare Andira Pharmaceuticals with similar companies based on industry and business-model similarity.

Andira Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Andira Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 12, 2026
Early FundingJun 14, 2023
GrantMar 1, 2022
SeedNov 23, 2021

Key People

Founding team and executive leadership

Dana M. Lambert

Chief Executive Officer

Executive Team

Andira Pharmaceuticals Investors

Notable investors and investment history

Andira Pharmaceuticals investors
InvestorRounds
US Capital Global SecuritiesEarly Funding
MitacsGrant
First FundSeed Round, Seed
The University of British ColumbiaGrant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    $152K Seed Round raised.

Andira Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Andira Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Andira Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range6
Year Founded2015
Last FundingMar 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.